Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders

NCT03232346 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03232346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2017
Completion date
June 30, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder